Invesco’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $95.9M | Buy |
1,277,358
+8,068
| +0.6% | +$637K | 0.01% | 852 |
|
|
2025
Q4 | $100M | Buy |
1,269,290
+750,220
| +145% | +$56.5M | 0.01% | 834 |
|
|
2025
Q3 | $34M | Buy |
519,070
+262,835
| +103% | +$12.8M | 0.01% | 1221 |
|
|
2025
Q2 | $10.1M | Sell |
256,235
-618,599
| -71% | -$20.2M | ﹤0.01% | 1768 |
|
|
2025
Q1 | $26.4M | Buy |
874,834
+86,235
| +11% | +$2.82M | 0.01% | 1304 |
|
|
2024
Q4 | $27.6M | Sell |
788,599
-21,702
| -3% | -$811K | 0.01% | 1333 |
|
|
2024
Q3 | $32.5M | Sell |
810,301
-158,616
| -16% | -$7.38M | 0.01% | 1225 |
|
|
2024
Q2 | $46.2M | Buy |
968,917
+526,030
| +119% | +$21.6M | 0.01% | 1046 |
|
|
2024
Q1 | $19.2M | Buy |
442,887
+236,986
| +115% | +$11.3M | ﹤0.01% | 1481 |
|
|
2023
Q4 | $10.4M | Buy |
205,901
+74,734
| +57% | +$3.58M | ﹤0.01% | 1791 |
|
|
2023
Q3 | $5.95M | Buy |
131,167
+1,449
| +1% | +$59.8K | ﹤0.01% | 2107 |
|
|
2023
Q2 | $5.32M | Sell |
129,718
-186,002
| -59% | -$7.15M | ﹤0.01% | 2213 |
|
|
2023
Q1 | $11.3M | Sell |
315,720
-6,727
| -2% | -$253K | ﹤0.01% | 1707 |
|
|
2022
Q4 | $12.2M | Buy |
322,447
+27,248
| +9% | +$1.15M | ﹤0.01% | 1711 |
|
|
2022
Q3 | $13.1M | Sell |
295,199
-30,786
| -9% | -$1.3M | ﹤0.01% | 1617 |
|
|
2022
Q2 | $12.1M | Buy |
325,985
+185,993
| +133% | +$7.01M | ﹤0.01% | 1709 |
|
|
2022
Q1 | $5.18M | Buy |
139,992
+7,750
| +6% | +$254K | ﹤0.01% | 2356 |
|
|
2021
Q4 | $4.02M | Sell |
132,242
-9,113
| -6% | -$287K | ﹤0.01% | 2511 |
|
|
2021
Q3 | $4.74M | Sell |
141,355
-199,258
| -58% | -$7.51M | ﹤0.01% | 2415 |
|
|
2021
Q2 | $13.6M | Sell |
340,613
-2,018,821
| -86% | -$79.1M | ﹤0.01% | 1864 |
|
|
2021
Q1 | $106M | Sell |
2,359,434
-1,025,435
| -30% | -$57.2M | 0.03% | 772 |
|
|
2020
Q4 | $191M | Buy |
3,384,869
+813,228
| +32% | +$40.5M | 0.06% | 446 |
|
|
2020
Q3 | $122M | Buy |
2,571,641
+231,896
| +10% | +$12.9M | 0.04% | 553 |
|
|
2020
Q2 | $138M | Sell |
2,339,745
-1,052
| -0% | -$58.5K | 0.05% | 469 |
|
|
2020
Q1 | $111M | Sell |
2,340,797
-14,229
| -0.6% | -$793K | 0.05% | 467 |
|
|
2019
Q4 | $142M | Sell |
2,355,026
-21,637
| -0.9% | -$1.29M | 0.04% | 520 |
|
|
2019
Q3 | $142M | Buy |
2,376,663
+105,124
| +5% | +$6.85M | 0.04% | 535 |
|
|
2019
Q2 | $146M | Buy |
2,271,539
+2,191,974
| +2,755% | +$155M | 0.04% | 540 |
|
|
2019
Q1 | $6.46M | Buy |
79,565
+29,583
| +59% | +$1.91M | ﹤0.01% | 1843 |
|
|
2018
Q4 | $2.7M | Sell |
49,982
-196,208
| -80% | -$10M | ﹤0.01% | 2339 |
|
|
2018
Q3 | $12.7M | Buy |
246,190
+43,172
| +21% | +$2.03M | ﹤0.01% | 1569 |
|
|
2018
Q2 | $8.46M | Buy |
203,018
+385
| +0.2% | +$17.1K | ﹤0.01% | 1778 |
|
|
2018
Q1 | $8.93M | Sell |
202,633
-18,873
| -9% | -$959K | ﹤0.01% | 1618 |
|
|
2017
Q4 | $11.1M | Buy |
221,506
+90,061
| +69% | +$4.94M | ﹤0.01% | 1513 |
|
|
2017
Q3 | $6.66M | Sell |
131,445
-195,231
| -60% | -$10.2M | ﹤0.01% | 1789 |
|
|
2017
Q2 | $16.6M | Buy |
326,676
+103,539
| +46% | +$4.82M | 0.01% | 1272 |
|
|
2017
Q1 | $8.97M | Buy |
223,137
+40,638
| +22% | +$1.83M | ﹤0.01% | 1609 |
|
|
2016
Q4 | $8.73M | Sell |
182,499
-71,049
| -28% | -$2.81M | ﹤0.01% | 1637 |
|
|
2016
Q3 | $9.29M | Sell |
253,548
-94,387
| -27% | -$2.95M | ﹤0.01% | 1553 |
|
|
2016
Q2 | $8.1M | Sell |
347,935
-306,940
| -47% | -$9.9M | ﹤0.01% | 1563 |
|
|
2016
Q1 | $26.5M | Buy |
654,875
+507,185
| +343% | +$20.6M | 0.01% | 1017 |
|
|
2015
Q4 | $9.15M | Sell |
147,690
-142,559
| -49% | -$7.69M | ﹤0.01% | 1527 |
|
|
2015
Q3 | $11.7M | Sell |
290,249
-31,807
| -10% | -$1.65M | 0.01% | 1383 |
|
|
2015
Q2 | $18.5M | Sell |
322,056
-191,905
| -37% | -$12.2M | 0.01% | 1249 |
|
|
2015
Q1 | $32.7M | Buy |
513,961
+184,643
| +56% | +$12.5M | 0.01% | 998 |
|
|
2014
Q4 | $20.3M | Buy |
329,318
+9,400
| +3% | +$464K | 0.01% | 1162 |
|
|
2014
Q3 | $12.4M | Sell |
319,918
-56,026
| -15% | -$1.99M | 0.01% | 1419 |
|
|
2014
Q2 | $13M | Sell |
375,944
-31,554
| -8% | -$994K | 0.01% | 1419 |
|
|
2014
Q1 | $17.6M | Buy |
407,498
+33,462
| +9% | +$1.62M | 0.01% | 1246 |
|
|
2013
Q4 | $14.9M | Buy |
374,036
+13,003
| +4% | +$463K | 0.01% | 1332 |
|
|
2013
Q3 | $13.6M | Buy |
361,033
+34,611
| +11% | +$1.03M | 0.01% | 1311 |
|
|
2013
Q2 | $8.77M | Buy |
+326,422
| New | +$6.94M | ﹤0.01% | 1503 |
|
Other funds holding IONS
VPM
VCM
Invesco's IONS Position: Q1 2026 in Review
Invesco increased its Ionis Pharmaceuticals (IONS) stake by 0.64% in Q1 2026, buying an estimated $637K and bringing the position to 1,277,358 shares worth $95.9M. The position accounts for 0.01% of the portfolio, ranked #852.
Invesco first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. The position peaked at $191M in Q4 2020. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Invesco held 1,277,358 shares of Ionis Pharmaceuticals worth $95.9M as of Q1 2026.
- Invesco bought 8,068 Ionis Pharmaceuticals shares in Q1 2026, an estimated $637K.
- Ionis Pharmaceuticals made up 0.01% of Invesco's portfolio in Q1 2026, its #852 holding.
- Invesco first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Invesco's Ionis Pharmaceuticals position peaked at $191M in Q4 2020.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.